Evidence map›Paper›PMID 41071887›Full record

ArticleScience advances2025

Structural insights into the progressive recovery of α7 nicotinic acetylcholine receptor from nicotine-induced desensitization.

Sanling Liu, Haopeng Chen, Xiaohong Zhu, Fei Ye, Yue Zhao, Junlin Qin, Yining Zheng, Xudong Wang, Longhua Zhang, Huan Chen and 8 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sanling LiuBeijing Life Science Academy, Beijing, China.ORCID 0000-0002-0327-5558
Haopeng ChenHefei National Research Center for Physical Sciences at the Microscale, Division of Life Sciences and Medicine, Anhui Engineering Laboratory of Peptide Drug, University of Science and Technology of China, Hefei, Anhui, China.ORCID 0009-0004-2502-6351
Xiaohong ZhuChenzhu (MoMeD) Biotechnology Co., Ltd., Hangzhou, China.ORCID 0000-0003-3364-258X
Fei YeCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, Zhejiang, China.
Yue ZhaoHefei National Research Center for Physical Sciences at the Microscale, Division of Life Sciences and Medicine, Anhui Engineering Laboratory of Peptide Drug, University of Science and Technology of China, Hefei, Anhui, China.
Junlin QinSchool of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China.ORCID 0009-0007-6766-9787
Yining ZhengHefei National Research Center for Physical Sciences at the Microscale, Division of Life Sciences and Medicine, Anhui Engineering Laboratory of Peptide Drug, University of Science and Technology of China, Hefei, Anhui, China.
Xudong WangHefei National Research Center for Physical Sciences at the Microscale, Division of Life Sciences and Medicine, Anhui Engineering Laboratory of Peptide Drug, University of Science and Technology of China, Hefei, Anhui, China.
Longhua ZhangHefei National Research Center for Physical Sciences at the Microscale, Division of Life Sciences and Medicine, Anhui Engineering Laboratory of Peptide Drug, University of Science and Technology of China, Hefei, Anhui, China.
Huan ChenBeijing Life Science Academy, Beijing, China.
Xin LiBeijing Life Science Academy, Beijing, China.ORCID 0009-0009-3025-673X
Wenjun MuBeijing Life Science Academy, Beijing, China.
Yaning FuBeijing Life Science Academy, Beijing, China.
Cheng LuoSchool of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China.ORCID 0000-0003-3864-8382
Hongwei HouBeijing Life Science Academy, Beijing, China.ORCID 0000-0001-9389-4928
Chen BaiChenzhu (MoMeD) Biotechnology Co., Ltd., Hangzhou, China.ORCID 0000-0003-4560-3019
Lei LiuDepartment of Chemistry, Tsinghua University, Beijing, China.ORCID 0000-0001-6290-8602
Changlin TianBeijing Life Science Academy, Beijing, China.ORCID 0000-0001-9315-900X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nicotine is the predominant alkaloid in tobacco leaves and affects the human nervous system by interacting with nicotinic acetylcholine receptors (nAChRs). Chronic nicotine exposure leads to nAChR desensitization, while nicotine withdrawal leads to nAChR recovery. However, detailed molecular mechanisms underlying nicotine-induced nAChR desensitization and its recovery remain elusive. Here, we present cryo-EM structures of the α7 nAChR in complex with nicotine in both an open state and multiple desensitized states. Comparative analyses reveal progressive conformational changes during recovery from nicotine-induced desensitization and show that asymmetric nicotine binding disrupts the symmetry of the channel pore at the 16' and 17' sites. Integrating these findings with patch-clamp recordings and computational simulations, we identify an agonist-free structure that represents an atypical desensitized state closely resembling the resting conformation of α7 nAChR. These detailed mechanistic studies enhance our understanding of nicotine's effects on α7 nAChRs.

Indexed as

alpha7 Nicotinic Acetylcholine ReceptorNicotineBinding SitesCryoelectron MicroscopyHumansModels, MolecularProtein BindingProtein Conformationalpha7 Nicotinic Acetylcholine ReceptorNicotine

Identifiers

PMID41071887
PMCPMC12513420

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.